Sensible Medical Innovations Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients

A trial with no phase registered on ClinicalTrials.gov. The registry status is terminated. It plans to enroll 380 participants.

Also called NCT02448342

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; no masking; primary purpose prevention
Phase
Not applicable
Enrolled
  • 380 participants (planned count) (from the registry)
Sponsor
Sensible Medical Innovations Ltd. (from the registry)
Registry
  • NCT NCT02448342
Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Countries
United States (from the registry)
Registry status
  • Terminated (from the registry)

Technical summary

Registry record NCT02448342. Randomized; no masking; primary purpose prevention. Start 2015-09 (actual); primary completion 2017-11-30 (actual). Results not posted.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
Sensible Medical Innovations Lung fLuid Status Monitor Allows rEducing Readmission Rate of Heart Failure Patients
Acronym
SMILE™
Condition
Heart Failure
Intervention (Device)
Remote Dielectric Sensing (ReDS) Wearable System
Lead sponsor
Sensible Medical Innovations Ltd. (class: industry)

Record details

Record id
cardio:ct-nct02448342
Content hash
5852ecad88fb290502cb8c13eea8128aabe28535cb07955ada0d72da1e63e4ba